Contact Us

Service Line:+1-315-239-3085

Address:FL-4, Building A5, International Enterprise Community, Tianjin, China

Email:info@kmdbioscience.com

Online Inquery

  •   
  •   
  •   
  • Refresh

Anti-Human APP Abeta Recombinant Antibody(Aducanumab)

Product Information
Catalog Number YR1321
Product Name Anti-Human APP Abeta Recombinant Antibody(Aducanumab)
Molecular Name Aducanumab
Alias Anti-APP Abeta Recombinant Antibody, Research Grade Aducanumab
CAS Number 1384260-65-4
Target APP Abeta[Homo sapiens]
Isotype IgG1 Kappa
Clonity Monoclonal
Source CHO Cells
Size 1mg, 5mg
Concentration 1mg/ml
Purity >95% as determined by SDS-PAGE
Buffer PBS, pH7.5
Background Aducanumab, sold under the brand name Aduhelm, is a medication used to treat Alzheimer's disease (AD). It is an amyloid beta-directed monoclonal antibody. Aducanumab targets aggregated forms of Amyloid beta (Aβ) found in the brains of people with Alzheimer's disease to reduce its buildup.
Storage It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Note This product is for research use only.